Global Liquorice Extract Market 2021–2031: Size, Share, Trends and Forecast
The global liquorice extract market reached USD 2.32 billion in 2025 and will expand to USD 3.52 billion by 2031, advancing at a 7.2% CAGR. Pharmaceutical, nutraceutical and personal-care formulations are broadening demand beyond the market's established confectionery, beverage and tobacco applications. Asia-Pacific accounted for 37.8% of 2025 revenue, supported by China's extraction base, Japan's high-value derivatives sector and the region's extensive use of Glycyrrhiza in traditional medicine. Supply-chain control, glycyrrhizin standardisation, contaminant testing and traceable harvesting will determine which processors capture the industry's premium growth.
À la commande, tous les chiffres sont finalisés et vérifiés pour votre exemplaire, et le rapport complet est livré sous 24 à 72 heures.
Market size & forecast
Key findings
Key report takeaways
Global Liquorice Extract Market Trends and Growth Drivers
Liquorice extract sits at the intersection of flavour, botanical medicine and high-value cosmetic actives. Its commercial value depends not only on extract tonnage but also on species, glycyrrhizin concentration, flavonoid profile, colour, solubility, contaminant status and the depth of the supplier's regulatory documentation.
Demand is bifurcating between cost-sensitive conventional extracts and premium standardised ingredients. Confectionery and tobacco buyers continue to absorb blocks, pastes and powders, while pharmaceutical, nutraceutical and personal-care customers increasingly purchase DGL, purified salts, glycyrrhetinic acid, glabridin and licochalcone A.
Supply resilience is becoming as important as extraction efficiency. Root regeneration requires multiple years, and buyers are responding with dual-origin procurement, contracted cultivation, harvest protocols and tighter incoming-lot testing.
Growth drivers
Liquorice has an established position in traditional medicine, cough and throat preparations, digestive-health products and multi-herb formulas. Growth is moving toward standardised extracts with defined glycyrrhizin or flavonoid content, allowing pharmaceutical and supplement manufacturers to control dosage, substantiate specifications and support premium pricing.
Glabridin, licochalcone A, dipotassium glycyrrhizinate and glycyrrhetinic acid are gaining formulation roles in soothing, brightening and blemish-care products. Japanese, Korean, Chinese and European personal-care manufacturers are increasing demand for high-purity, low-colour and fully documented grades.
Glycyrrhizin delivers intense sweetness alongside masking, mouthfeel and flavour-extension functionality at low inclusion rates. Beverage, confectionery and flavour-system developers are using liquorice-derived solutions to soften bitterness and rebuild sensory intensity in reduced-sugar formulations.
Medicated lozenges, herbal pastilles, gummies and premium liquorice confectionery provide a stable volume base and a route for higher-value extract grades. Product development increasingly combines flavour with throat-soothing, digestive or botanical-positioning claims.
Deglycyrrhizinated liquorice widens the addressable market by separating selected flavour and flavonoid benefits from high glycyrrhizin exposure. Suppliers that can preserve sensory or bioactive performance while meeting tight residual-glycyrrhizin specifications are securing nutraceutical and personal-care contracts.
Traditional Chinese, Japanese Kampo, Korean and Indian herbal-product manufacturers are replacing variable raw botanicals with controlled extracts in selected formulations. Modern extraction capacity, quality documentation and retail distribution are converting established cultural usage into scalable ingredient demand.
Restraints
Excessive glycyrrhizin intake is associated with blood-pressure and potassium-related concerns, making dosage control central to food, supplement and pharmaceutical formulation. European warning thresholds and buyer-specific limits increase reformulation, testing and label-management costs, particularly for concentrated products.
Commercial roots commonly require several years to mature or regenerate, while a substantial share of supply remains wild or semi-wild harvested. Aggressive collection, drought and weak local resource governance can tighten availability and increase raw-material price volatility.
Liquorice roots and concentrated extracts require robust testing for ochratoxin A, aflatoxins, pesticides, heavy metals, microbes, residual solvents and species identity. Failed lots create disproportionate losses because extraction concentrates both desired compounds and upstream quality defects.
Important root and intermediate-extract flows originate in Uzbekistan, Turkmenistan, Afghanistan, Iran, China and neighbouring markets. Sanctions exposure, border congestion, currency restrictions and payment friction raise inventory requirements and favour companies with diversified sourcing networks.
Driver and restraint impact on the forecast
Each factor's directional pull on the forecast CAGR. Impacts are directional, not additive.
Liquorice Extract Market Segmentation Analysis
Powders dominate because they provide accurate dosing, longer shelf life and straightforward incorporation into tablets, capsules, dry beverage mixes and confectionery systems. Liquid extracts are expanding in beverages, syrups and personal care, while paste and block formats retain a strong position in traditional confectionery and tobacco processing. Granules and low-dust formats will grow fastest as industrial users automate handling and seek cleaner production environments.
Conventional extracts remain the largest category because they serve flavouring, sweetness, tobacco and traditional pharmaceutical applications. DGL is expanding in digestive-health products, where controlled residual glycyrrhizin supports regular-use positioning. Purified derivatives and flavonoid-rich extracts deliver the fastest value growth through high-purity cosmetic, pharmaceutical and specialist nutraceutical applications.
Pharmaceutical and nutraceutical demand leads because standardised extracts and derivatives command higher prices than bulk flavour grades. Food and confectionery remain the largest physical-volume outlet, supported by Nordic and continental European liquorice products and global throat-care confectionery. Cosmetics and personal care will post the fastest CAGR as glabridin, licochalcone A and glycyrrhizinate salts gain use in soothing and pigmentation-focused formulations, while tobacco demand grows slowly under tightening flavour regulation.
G. glabra leads through its established use in European, Middle Eastern and Central Asian supply chains and its importance in glabridin-rich extracts. G. uralensis is central to Chinese and East Asian medicinal formulations and benefits from cultivation and processing scale. G. inflata occupies a smaller share but is strategically important for licochalcone A, giving it the fastest growth rate among the major species.
Wild and semi-wild roots remain dominant across Central Asia and the Middle East because established natural stands provide competitive raw-material economics. Cultivated supply is growing faster as regulated buyers demand traceability, consistent active profiles and documented agricultural practices. Integrated processors are investing in contracted cultivation and regeneration protocols to reduce exposure to collection restrictions and inconsistent root quality.
Liquorice Extract Market Regional Analysis and Country Outlook
Asia-Pacific held 37.8% of global revenue in 2025 and is forecast to grow at 8.8% annually through 2031. China combines root access, extraction capacity and large pharmaceutical, traditional-medicine and cosmetics industries, while Japan specialises in purified glycyrrhizin salts, glycyrrhetinic-acid derivatives and sophisticated personal-care grades. India is building demand around digestive health, herbal supplements and branded DGL ingredients, and South Korea contributes rapid growth through calming and brightening skincare.
Europe accounted for 28.6% of 2025 revenue, with Germany, France, Italy, the Netherlands and the Nordic markets anchoring demand. France and Germany function as formulation, refining and redistribution centres, while Nordic confectionery consumption supports a distinctive food-grade customer base. Regulation increases compliance costs but also supports higher realised prices for traceable extracts with validated glycyrrhizin and ochratoxin specifications.
North America represented 23.4% of 2025 sales. The United States is a major import market for HS 130212 and supports premium demand from flavour houses, dietary-supplement brands, throat-care manufacturers and personal-care formulators. Latin America and the Middle East and Africa remain smaller in value but offer growth in beverages, traditional remedies and locally processed botanicals; the Middle East also remains strategically important as a root-sourcing and primary-extraction region.
Liquorice Extract Market Competitive Landscape and Company Share
The market is moderately concentrated. MAFCO Worldwide, Norevo, Maruzen Pharmaceuticals, BGG World and established Iranian and Central Asian processors hold strong positions through root procurement, extraction knowledge, customer approvals and product breadth. No single supplier controls all end-use markets because food-grade blocks, pharmaceutical derivatives, DGL extracts and cosmetic actives require different production assets and commercial channels.
Global specialists compete through multi-origin sourcing, application laboratories, contaminant-control systems and customised active-content specifications. Regional suppliers such as Sepidan Osareh, F&C Licorice, Zagros Licorice and ASEH retain an advantage in root access and primary conversion, while Maruzen, BGG, Natural Remedies and broader botanical-ingredient groups compete more heavily in purified, standardised and clinically positioned products.
Strategic activity is centred on downstream value addition rather than large-scale consolidation. Investment is flowing into low-dust powders, water-dispersible formats, DGL, high-purity glabridin, licochalcone A, analytical laboratories and traceable sourcing. Partnerships with cosmetics, nutraceutical and flavour customers are becoming more important because application support and regulatory dossiers raise switching costs.
Each company profile covers:
Liquorice Extract Market Forecast and Commercial Opportunities
The market will add USD 1.20 billion between 2025 and 2031. Pharmaceutical, nutraceutical and personal-care applications will contribute the majority of incremental value, while conventional confectionery and tobacco uses will remain substantial but grow more slowly. Product mix will shift from undifferentiated blocks and pastes toward standardised powders, purified derivatives and application-specific systems.
The central forecast assumes stable access to Central Asian and Chinese roots, continued acceptance of liquorice derivatives in regulated formulations and sustained demand for natural sensory solutions. A tighter-harvest scenario would lift prices and nominal market value but constrain physical volumes, whereas faster cultivated-root expansion would improve supply stability and support broader use in mass-market food and personal care.
Winning suppliers will combine botanical identity assurance, active-content consistency, low contaminant levels, documented regeneration practices and regional application support. The strongest commercial opportunities lie in DGL digestive-health products, high-purity cosmetic actives, reduced-sugar flavour systems and pharmaceutical-grade glycyrrhizin derivatives.
Regulation and taxation
Excise, labelling and distribution rules shape where and how the market competes. The regimes that matter most here:
Recent industry developments
Report scope
Market definition. The liquorice extract market comprises business-to-business sales of concentrated ingredients obtained from the roots and rhizomes of Glycyrrhiza species, principally G. glabra, G. uralensis and G. inflata. Covered products include liquid extracts, pastes and blocks, powders, granules, deglycyrrhizinated liquorice, standardised flavonoid extracts and commercial glycyrrhizin or glycyrrhetinic-acid derivatives supplied for food, beverages, tobacco, pharmaceuticals, dietary supplements, cosmetics and personal care.
Table of contents
List of figures (20)
List of tables (50)
Liquorice Extract Market Research Methodology
The study combines producer-level supply mapping, HS 130212 trade analysis, end-use consumption modelling, price benchmarking and structured primary research. Market value is measured at the first commercial sale of liquorice extract or derivative to an unaffiliated downstream customer, preventing double counting across extractors, distributors and formulators.
The bottom-up model aggregates producer output by form, grade and destination, applying region-specific realised prices and channel adjustments. Results are reconciled against a top-down consumption model covering confectionery, beverages, tobacco, pharmaceuticals, nutraceuticals and personal care.
Forecasts incorporate end-market production, botanical-ingredient penetration, product-mix upgrading, active-grade pricing, root availability, trade conditions and regulation. Base, upside and downside scenarios vary cultivated supply, pharmaceutical adoption and contaminant-related rejection rates.
Supplier, trade and end-use estimates are triangulated, validated through expert interviews and reviewed by senior food-ingredients and botanical-markets analysts.
Interviews validated extract yields, regional root-price ladders, realised prices by form and purity, DGL residual-glycyrrhizin specifications, application demand, distributor margins and supplier shares. They also established how buyers distinguish conventional extract, pharmaceutical-grade derivatives and cosmetic flavonoid concentrates.
Frequently asked questions
How large is the global liquorice extract market?
The global liquorice extract market was valued at USD 2.32 billion in 2025.
What is the forecast size of the liquorice extract market in 2031?
The market will reach USD 3.52 billion by 2031.
What CAGR will the liquorice extract market record?
Global revenue will grow at a 7.2% CAGR from 2025 to 2031.
Which region has the largest liquorice extract market?
Asia-Pacific led with 37.8% of global revenue in 2025, supported by Chinese extraction capacity and strong pharmaceutical, traditional-medicine and cosmetics demand.
Which region is growing fastest?
Asia-Pacific is the fastest-growing region, with an 8.8% CAGR through 2031.
Which liquorice extract form leads the market?
Powdered and spray-dried extracts led with 46.2% of 2025 revenue due to dosing accuracy, stability and broad compatibility with dry formulations.
Which application generates the most demand?
Pharmaceuticals and nutraceuticals generated 34.6% of 2025 market value and will grow at an 8.5% CAGR.
Who are the leading liquorice extract suppliers?
Leading suppliers include MAFCO Worldwide, Norevo, Maruzen Pharmaceuticals, BGG World, F&C Licorice, Sepidan Osareh, Zagros Licorice and ASEH Licorice.
What products are included in the liquorice extract market?
The market includes liquid, paste, block, powder and granular extracts, DGL, flavonoid-rich extracts and commercial glycyrrhizin or glycyrrhetinic-acid derivatives.
Why is deglycyrrhizinated liquorice gaining share?
DGL supports digestive-health and regular-use formulations that require tightly controlled residual glycyrrhizin while retaining selected liquorice flavonoids and functional properties.
What is the main raw-material risk?
The central risk is dependence on wild and semi-wild roots with multi-year regeneration cycles across Central Asia, China and the Middle East.
Which compliance issue most affects food-grade extracts in Europe?
Suppliers must manage glycyrrhizin-related labelling thresholds and the EU's 80 micrograms per kilogram ochratoxin A maximum for pure, undiluted food-use liquorice extract.
Have a question about this report?
Ask about scope, methodology, country coverage, customization or sample data — an analyst replies within 24 hours.